The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지

Antitumor Effects of Bigihwan on Tumor Cells derived from Leukemia and Lymphoma Patients

비기환(?氣丸)이 백혈병(白血病)과 임파종(淋巴腫) 환자(患者)에서 추출(抽出)한 암세포(癌細胞)에 미치는 항암효과(抗癌效果)

  • Han, Sang-Il (Dpt. of Oriental Medicine Graduate School, Won Kwang University) ;
  • Kang, Byung-Ki (Dpt. of Oriental Medicine Graduate School, Won Kwang University)
  • Published : 1991.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

Bigihwan which has been widely used in Oh-jug in oriental Medicine was investigated on its antitumor effect employing blood cancer cell lines. K 562 derived from human erytholeukemia, Raji from lymphoma and $MO_4$ from hlastogenic cancer were used in this study to see the analytical evaluation of Bigihwan' s antitumor effect using three different kinds of methods such as $^{3}H-thymidine$ up take assay. MTT assay and live cell counts by Trypan blue assay. The result obtained are as follows. 1. When higher than 10% Bigihwan was treated. inhibitory effect of tumor killing action was observed showing the increasing order of $MO_4$, K 562 and Raji(Fig. 3). 2. When 1 to 5% of Bigi-hwan was treated, 4 to 30% of tumor cell survival was observed according to various blood tumor cell lines suggesting that antitumor effect of Bigi-hwan was different as the characteristics of tumor cells showing 70 to 95% cell killing effent(Fig. 4). 3. Compared the survivals of cells by relative scales though the initial cpm was variable because of different cell growth rate. Raji was most effective being killed 95% by the treatment of 1% Bigihwan while Raji and K562 showed 93% by 5% Bigihwan.(Fig. 5) 4. The survival rate of Raji derived from Burkitt lymphoma was rather increased to 2.3 times when Bigihwan concentration was increased from 1 to 10% lmplying of refraining from over use of this anticancer drug. specially to lymphoma patients(Fig. 5). 5. Bigihwan was most effective to K 562 and then $MO_4$ showing 95% tumor cell death by using 1% of this anticancer drug while it was least effective to Raji showing only 68% of tumor cell death(Fig.7). 6. Judging from the all the analytical methods used in this study, through all different three tumor cell lines. Bigihwan was most effective to K 562 derived from human erythroleukemia.

Keywords

References

  1. 中醫內科學 江蘇信醫學院 中醫內科敎硏組(編)
  2. 靑襄決 南采祐
  3. 醫學綱目 v.25 樓全善
  4. 肝係內科學 金秉震(外)
  5. 日本藥用植物圖鑑 木村康一(外)
  6. 中醫內科學 上海中醫學院
  7. 腫瘍學 서울대학교 의과대학(編)
  8. 醫學門俓 徐學山
  9. 中藥大辭典 新文豊出版公司
  10. 臨庠本草學 辛民敎
  11. 中醫腫留學 郁仁存
  12. 腫留任證작要 李岩
  13. 腫留炳 李岩
  14. 國譯醫方集骸 江昻
  15. 腫留的辨證施治 錢伯文
  16. 醫門寶鑑 周命新
  17. 中醫內科槪要 中醫學會
  18. 東醫寶鑑 許浚
  19. 趙永植 博士 華甲紀念 論文集 數種 漢藥劑가 制癌制 및 Glucocorticoid의 抗體 生産 抑制作用에 미치는 影響 金光湖(外)
  20. Arch. Pharmacolx Rres. v.8 no.4 Effect of antitumor polysaccharides from Albizza julibrissin on Immune function Moon, Cha Kiu;Lee, Byeong Gon;Lee, Soo Whan;Kang, Tak Lim
  21. 圓光大學校 碩士學位論文 伏梁丸이 白血病과 肝癌患者에서 抽出한 癌細胞에 미치는 抗癌效果 金剛山
  22. 慶熙韓醫大論文集 v.9 數種의 漢藥物이 癌細胞 感受性에 미치는 影響 任帝訓
  23. Yaoxue Tongbao v.19 no.9 Constituents of the essential oil from rhizome of Attactylodes macrocephala produced in pingjiang(China) and their antitumor effects Tang, Defang;Hao, Yohung;Miao, Shulin;Wei, Hua;Wu, Jian
  24. Antitumor agents from medical plants Sasaki, S.
  25. Effects of on cancer cell Odajima, Yoshio
  26. Tubular summary of pharmacokinetic parameters relavant to in vitro drug assay : cloning of human tumor stem cells Albert, D.S.;Chen, H.S.G.
  27. Lancet Predicting responses of human cancer to chemotherapy Beren, Baum M.C.
  28. In vitro assays of chemotherapeutic sensitivity important advances in oncology Carney, D.N.;Winkler, C.F.
  29. Cancer Research v.41 Differential killing efficacy of twenty antitumor drugs on proliferating and non proliferating human tumor cells Drewinko, B.;Patchen, M.L.Y.(et al.)
  30. Cancer Research v.39 A methodological approach to the prediction of anticancer durg effect in humans Durkin, W.J.;Ghanta, V.K.;Balch, C.M.(et al.)
  31. Cancer Research v.48 Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay Alley, M.C.;Scudiero, D.A.;Monks, A.(et al.)
  32. Eur. J. Cancer Clin. Oncol. v.22 Comparison of in vitro activity of ctytotoxic drugs towards human cancionoma and leukemia cell lines Finlay, G.J.;Wilson, W.R.;Baguley, B.C.
  33. Int. J. Radiat Oncol. Biol. Phys. v.15 no.3 Use of a colorimetric microtiter (MTT) as say in determining the radiosensitivity of cells from murine solid tumors Waserman, T.H.;Twentyman, P.
  34. Oncology Sodium succinate enhances the colorimetric reaction of the in vitro chemosensitivity test : MTT assay Maehara, Y.;Kusumoto, T.;Kusumoto, H.;Anai, H.;Sugimachi, K.
  35. J. Immunol. Methods v.119 no.2 Re-examination and further development of a precise and rapid method for measuring cell growth/cell kill Hansen, M.B.;Nielsen, S.E.;Berg, K.
  36. Cancer Research v.49 no.15 Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide formazan absorption chemosensitivity determined by a novel tetrazoliumbased assay Plumb, J.A.;Milroy, R.;Kaye, S.B.
  37. Cancer Lett. v.41 no.3 Adaptation of the rapid automated tetrazolium dye base (MTT) assay for chemosensitivity testing in childhood leukemia Pieters, R.;Huismans, D.R.;Leyva, A.;Veerman, A.J.
  38. Cancer Chemother Pharmacol. v.22 no.3 In vitro antitumor activity of mitomycin C derivative(RM-49) and new anticancer antibitis (FK973) against lung cancer cell lines determined by tetrazolium dye (MTT) assay Horiuchi, N.;Nakagawa, K.;Sasaki, Y.;Minato, K.;Fujiwara, Y.;Nezu, K.;Ohe, Y.;Saijo, N.
  39. Cancer Res. v.47 Evaluation of a tetrazolium based on semiautonatic Colorimetic assay : assessment of radiosensitivity carmichael, J.;Degraff, W.G.;Gazdar, A.F.;Minna, J.D.;Mitchell, J.B.
  40. Cancer Res. v.47 Chemosensitivity testing of human coloretal carcinoma cell lines using a tetrazolium based colorimetric assay Park, J.G.;Kramer, B.S.;Steinberg, S.M.
  41. J. Natl. Cancer Inst. v.66 Uses of in vitro tests in predictive cancer chemotherapy Hamburger, A.W.
  42. v.12 The human tumor cloning assay in cancer research and therapy current problems in cancer Hanauske, A.R.;Hanauske, U.;Von Hoff, D.D.
  43. Cancer Research v.83 Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor Heppner, G.H.;Dexter, D.L.;DeNucci, T.(et al.)
  44. Arch. Surg. v.117 Clinical correlations with drug sensitivities in the clonogenic assay Mann, B.D.;Kern, D.H.;Giuliano, A.E.(et al.)
  45. Cancer v.52 Predictability of responser to chemotherapy by the clonogennic assay Mann, B.D.;Kristian, Strom F.;Morton, D.L.(et al.)
  46. J. Immunol. Methods v.65 Rapid colorimetric assay for cellular growth and survival : application to proliferation and cytotoxicity assay Mosmarm, T.
  47. Cancer Research v.37 Improved growth of in vitro colonies in human accute leukemia with feeding culture method Park, C.H.;Savin, M.A.;Hoogstraten, B.(et al.)
  48. Cancer Research v.32 Comparison of in vitro methods to determine drug induced cell lethality Roper, P.R.;Drewinko, B.
  49. N. Eng. J. Med. v.298 Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs Salmon, S.E.;Hamburger, A.W.;Soehnlen, B.(et al.)
  50. Br. J. Cancer v.41 Experimental chemotherapy studies : Intercomparison of assays Twentymen, P.R.
  51. Seminars in Oncology v.4 In vitro assays in preclinical antineoplastic drug screening Weisenthal, L.M.
  52. Cancer trean Rep. v.6 Clonogenic and non clogenic in vitro Chemosensitivity assays Weisenthal, L.M.
  53. Cancer treat Rep. v.68 Origins and development of chemotherapy research at the National Cancer Institute Zubod, C.G.
  54. Antitumor agents from medical plants Sasaki, S.
  55. Effects of Ginseng on cander cell Odajima, Yoshio
  56. J. Exp. Med. Monoclonal cytotoxic T cell lines Baker, P.R.;Gillis, S.;Smith, A.K.
  57. J. Immunol. Methods v.89 Human interleukin 2 : quantitation by a sensitive radioimmunoassay Cardenas, J.M.;Marshall, P.;Henders, On, B.;Altman, A.
  58. J. Immunol. Methods v.65 Rapid colorimetric assay for cellular growth and survival : application to proliferation cytotoxic assay Mosman, T.
  59. Br. J. Cancer v.48 Failure of high doses of interferon to affect the growth of human carcinoma, melanoma and myeloed leukemia xenografts Clutterbuk, R.D.;Miller, J.L.;Alexander, P.
  60. N. Engl. J. Med. v.311 Treatment of advanced non-Hodgkins lymphoma with recombinant lekocyte A interferon Foon, K.A.;Sherwin, S.A.;Abrams, P.L.;Longo, D.L.;Fer, M.J.;Jaffe, R.S.;Oldham, R.K.
  61. Cancer Chemother Rep. v.3 no.III Protocols for screening chemical agent and natural products against animal tumors and other biological system Geran, R.I.;Greemberg, N.H.;Macdonald, M.M.;Schumacher, A.M.;Abbott, B.J.
  62. Ann Intern. Med. v.93 Leukocyte interferoninduced tumor regression in human metastatic breast cancer, multiple myeloma and malignant lymphoma Gutterman, J.U.;Blumenschein, G.R.;Alexanian, R.;Yap, H.Y.;Buzdar, A.U.;Cabanillas, F.;Hortobagyi, G.N.;Hersh, E.M.;Rasmussen, S.L.;Harmon, M.;Kramer, M.;Pestka, S.
  63. Proc. Natl. Acad Sci. U.S.A. v.69 Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes Lindahl, P.;Leary, P.;Gresser, I.
  64. Cancer Res. v.43 Renal cell carcinoma : Antitumor effects of leukocyte interferon Quesada, J.R.;Swanson, D.A.;Trindade, A.;Gutterman, J.U.
  65. Biken J. v.19 Antitumor effects of interferon on transplated tumors in congeintally athymic nude mice Yokota, Y.;Kishida, T.;Esaki, K.;Kawamata, J.